中国高校科技期刊研究会第9次会员代表大会在北京召开，中宣部出版局副局长张怀海、教育部科学技术与信息化司一级巡视员张国辉等领导出席会议并发表..
英文简介：The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal's scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.中文简介：（来自Google、百度翻译）国际临床化学和实验室医学联合会 (IFCC) 官方期刊 Clinica Chimica Acta是一本高质量的期刊，在临床化学和实验室医学领域发表原创研究通讯，定义为化学的诊断应用，生物化学，免疫化学，血液学的生化方面，毒理学和分子生物学，用于研究体液和细胞中的人类疾病。 该杂志的目的是发布新颖的信息，从而更好地了解人类疾病的生物学机制，预防，诊断和患者管理。也欢迎有关应用临床特征的报告。与正常代谢过程或正常细胞或体液成分有关的论文，例如动物实验或临床研究的报告，仅在与人类疾病明确直接相关时才考虑。除非商业产品新颖或代表技术突破，否则对商业产品的评估优先级较低。有关药物和天然产物的影响的研究以及有关各种疾病中氧化还原状态的研究不在该杂志的范围之内。还将考虑开发和评估适用于诊断临床化学和实验室医学的新型分析方法，包括护理点测试，以及有关实验室管理和信息学的主题。针对新兴诊断技术和 (大) 数据分析程序 (包括数字化，移动健康和应用于实验室医学的人工智能) 的研究也很有趣。
